این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Middle East Journal of Cancer، جلد ۱۶، شماره ۲، صفحات ۱۸۱-۱۸۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Stromal Cell-Derived Factor1 Genetic Variation at Locus 801 in Patients with Endometrial Cancer
چکیده انگلیسی مقاله Background: The gene's 3′ untranslated region of stromal cell-derived factor1 (SDF-1/ CXC chemokine ligand 12 (CXCL12)) contains a polymorphism, known as SDF1-3′A at location 801, and has been linked to various types of cancers. The present study aimed to evaluate the relationship between this polymorphism and genetic predisposition to endometrial cancer.
Method: In this case-control study, DNA was extracted from blood samples of 108 endometrial cancer patients and 123 healthy individuals through salting out method. Genotyping was done by restriction fragment length polymorphism-polymerase chain reaction method, and the data were analyzed using chi-square test.
Results: A total number of 67 (62%) patients emerged as GG genotypes, 35 (32.4%) with GA, and 6 (5.6%) with AA genotypes. The frequency of GG, GA and AA in healthy control group was found to be 68 (55.3%), 50 (40.6%) and 5 (4.1%), respectively. Furthermore, the most frequent allele in both patient (169 (78.25%)) and control (186 (75.6%)) groups was G allele. However, no significant difference was observed between genotypes and alleles frequencies between the two groups. Furthermore, no significant association was observed between genotypes distribution and menopausal status (P = 0.70), tumor size (P = 0.62), degree of tumor differentiation (P = 0.74), stage (P = 0.35), tumor type (P = 0.22), and myometrial invasion (P = 0.22).
Conclusion: Our results show that SDF1-3′A at location 801 may not enhance the risk of endometrial cancer. However, further research with a larger sample size is required to understand the molecular behavior of the SDF-1 gene polymorphism in endometrial cancer.
کلیدواژه‌های انگلیسی مقاله Endometrial neoplasms,Stromal cell-derived factor1,Chemokine CXCL12,Genotype
نویسندگان مقاله Fateme Sadat Najib |
Obstetrics and Gynecology Department, Infertility Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Elham Izanloo |
Obstetrics and Gynecology Department, Shiraz University of Medical Sciences, Shiraz, Iran

Maryam Aghdaki |
Obstetrics and Gynecology Department, Shiraz University of Medical Sciences, Shiraz, Iran

Soolmaz Khansalar |
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Mohammad Javad Fattahi |
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Zahra Oveisi |
Obstetrics and Gynecology Department, Shiraz University of Medical Sciences, Shiraz, Iran

Mohammad Reza Haghshenas |
Shiraz Institute for Cancer Research, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

نشانی اینترنتی https://mejc.sums.ac.ir/article_50278_ad26ca391c98ff7cff38b877ae2ba977.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات